1. Kashtan CE, Michael AF. Alport syndrome. Kidney İnt 1996;50: 1445-63.
2. Kissane JM. bernstein J. Hereditary nephritis. Edelman CM (editör). Pediatric kedney disease. Liftle Brown and Company, Boston, 1992. p. 1159-70.
3. Spear GS. Alprt's syndrome: a consideration of pat-hogenesis. Clin Nephrol 1973;1:336-7.
4. Atkin CL. Hassdedt SJ, Menlove L, Mapping of Alport syndrome to the long arm of the X chromosome. Am J Hum Genet 1988; 42: 249-55.
5. Brunner H.Schroder C. Van-Bennekom G, Localisation of the gene for X-linked Alport's syndrome. Kidney İnt 1988; 34: 507-10.
6. Flinten FA, Cameron JS, Chantfer C, Genetics of clas-sic Alport's syndrome. Lancet 1988; 2: 1005-7.
7. Barker DF, Hostikka SL, Zhou J, Identification of mu-tations the COL4A5 collağen gene in Alport syndrome. Science 1990; 248:1224-7.
8. Hostikka SL, Eddy RL, Byers MG. Identification of a distinc type IV coliagen a chain with restricted kidney distribution and assignment of its gene to the locus of X chromosornelinked Alport syndrome. Proc Natl Acad Sci USA 1990; 87:1606-10.
9. Smeets HJ, Knoers VV, van de Heuvel LP, Hereditary disorders of the glomerular basement membrane. Pe-diatr Nephrol 1996; 10: 779-88.
10. Tryggvason K, Heikküa P, Petterson E, Can Alport
syndrome be treated by gene therapy? Kidney İnt
1997;51:1493-9.
11. Gautrier B, Kashtan CH. Hereditary nephropathies. Go-
nick HC (editör). Current Nephrology. St. Louis,
Mosby-Year Book, İne, 1996. p. 127-67.
12. Leinonen A, Maryama M, Mochizuki T, Complete pri-mary strueture of the human type IV collagen a4(IV) chain. J Biol Chem 1994; 269: 26172-7.
13. Tsilibary E, Charonis A. The role of the main non-coliagenous domain (NC1) in type İV coiiagen self-assembly. J Celi Biol 1986; 103: 2467-73.
14. Aumailley M, Timpl R. Attachmenî of cells to basement membrane collagen type IV. J Celi Biol 1986; 103: 1569-75.
15. Butkowski RJ, VVİeslander J, Kleppel M, Basement membrane collagen in the kidney: Regional localization of novel chains reiated to collagen İV. Kidney İnt 1989; 35:1195-202.
16. Netzer KO, Renders L, Zhou J, Deletions of the COL4A5 gene in patients with Alport syndrome. Kidney İnt 1992; 42: 1336-44.
17. Zhou J. Mochizuki T, Smeets H, Deletion of the paired a5(IV) and a6(!V) collagen henes İn inherited smooth muscle tumors. Science 1993; 261: 1167-9.
18. Thompson SM, Deady JP, Willshaw HE, Ocular signs in Alport's syndrome. Eye 1987; 1:146-53.
19. Brivet F, Girot R, Barbanel C, Hereditary nephritis as-sociated with May-Hegglin anomaly. Nephron 1981; 29: 59-62.
20. Rumpelt HJ. Alpor's syndrome: Specifity and pat-hogenesis of glomerular basement membrane al-terations Pediatr Nephrol 1987; 1: 422-7.
21. Kohaut EC, Singer DB, Nevels BK, The specifity of split renal membranes in hereditary nephritis. arch Pathol LabMed 1976: 100: 475-9.
22. Gobel J, Olbricht CJ, Offner G, Kidney transplantation in Alport's syndrome: Longterm outeome and allograft anti- GBM nephritis. Clin Nephrol 1992; 38: 299-304.
23. Ding. J, Stitzel J, Berry P, Autosomal recessive Alport syndrome: Mutation in the COL4A3 gene in a vvoman with Alport syndrome and posttransplant antiglomemlar basement membrane nephritis. J Am Soc Nephrol 1995; 5: 1714-7.
Thank you for copying data from http://www.arastirmax.com
